Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Callet-Bauchu

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Leukemia|December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes, D Oscier, C Montalban, et al.
Nature Genetics|May 13, 1999
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Q Zhang, R Siebert, M Yan, et al.
Leukemia|August 21, 2009
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)I Nagel, S Bug, H Tönnies, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Leukemia|May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocationJ I Martín-Subero, R Ibbotson, W Klapper, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Leukemia|December 21, 2007
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaE Matutes, D Oscier, C Montalban, et al.
Nature Genetics|May 13, 1999
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Q Zhang, R Siebert, M Yan, et al.
Leukemia|August 21, 2009
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)I Nagel, S Bug, H Tönnies, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Leukemia|May 15, 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocationJ I Martín-Subero, R Ibbotson, W Klapper, et al.
Pageof 3